Related Experiment Video

Updated: Jun 3, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Pediatric multiple sclerosis

Tanuja Chitnis1, Lauren Krupp, Ann Yeh

  • 1Harvard Medical School, Partners Pediatric Multiple Sclerosis Center, Massachusetts General Hospital for Children, 55 Fruit Street, Boston, MA 02114, USA.

Neurologic Clinics
|March 29, 2011
PubMed

Insights

Knowledge about pediatric multiple sclerosis (MS) has rapidly advanced, improving diagnosis and treatment. Further research is needed to fully understand this complex neurological condition in children and adolescents.

Area of Science:

  • Neurology
  • Pediatrics
  • Immunology

Background:

  • Pediatric multiple sclerosis (MS) is a rare but significant autoimmune neurological disorder affecting young individuals.
  • Recent years have seen substantial progress in understanding the epidemiology, pathophysiology, and clinical manifestations of MS in children and adolescents.

Purpose of the Study:

  • To provide a comprehensive overview of the current knowledge regarding pediatric MS.
  • To identify and discuss critical areas requiring further scientific investigation and research.

Main Methods:

  • Literature review of recent publications (past 5 years) on pediatric MS.
  • Synthesis of existing data on diagnosis, pathogenesis, clinical course, and treatment.

Main Results:

  • Significant growth in understanding pediatric MS diagnosis, pathogenesis, clinical course, and treatment.
  • Identification of several key areas within pediatric MS that warrant additional research and exploration.

Conclusions:

  • The field of pediatric MS has evolved considerably, with notable advancements in clinical and scientific understanding.
  • Continued research is essential to address remaining knowledge gaps and optimize management strategies for young MS patients.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy07:20

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy

Published on: August 9, 2024

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...